Robert L. Barry

Stasys Medical Corp. operates as a medical device company. The firm's system is a device that tests small volumes of blood for platelet function. The company was founded by Robert Barry, Nate Sniadecki and Nathan White in 2013 and is headquartered in Kirkland, WA.

Part of Merit Medical Systems, Inc., Universal Medical Instruments, Inc. is a company that manufactures medical devices. The company is based in Ballston Spa, NY. Universal Medical Instruments was acquired by Merit Medical Systems, Inc. on January 15, 1997.

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

CoAptus Medical Corporation is an early stage medical device company developing a therapeutic product for the treatment of a structural heart defect called a patent foramen ovale, or PFO. A PFO is a flap-like opening, or tunnel between the upper chambers of the heart. Normally, this passageway closes shortly after birth. However, in approximately 25% of the population, the passageway remains open or patent, and may permit the passage of blood clots or chemicals that would normally be filtered by the lungs to pass into the left heart and into the arterial circulation of the body including the brain. PFO's have been associated with stroke, transient ischemic attacks (TIA's), and migraine headaches. CoAptus is developing a non-implant, therapeutic catheter device to coapt the tunnel tissues closed and apply RF energy for a permanent seal. Nothing is left behind in the heart after the procedure is completed.

Spiration, Inc. developed, manufactured and marketed medical devices for the treatment of air leaks and lung disease. The company was founded in 1999 and was headquartered in Redmond, WA.

Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA.